Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurologist. 2009 Jan;15(1):1-5. doi: 10.1097/NRL.0b013e31817acf1a.

Relapse management in multiple sclerosis.

Author information

  • 1Shepherd MS Institute, Atlanta, Georgia 30309, USA. ckernich2@sbcglobal.net

Abstract

Relapses, exacerbations, and attacks are synonymous for new or worsened neurologic symptoms that are the hallmark of relapsing-remitting multiple sclerosis. Management of relapses is not always straightforward. The clinician must distinguish between true relapses, symptom fluctuation, and pseudo-relapses. Risks and benefits of treating a relapse must be considered. Once the decision to treat is made, most clinicians would pursue a course of corticosteroids. Consensus may end there, as there is no clear-cut "best" route of administration or dosing schedule. The patient presenting with their first relapse or clinically isolated syndrome may be at risk for the development of multiple sclerosis. Clinical presentation, CSF findings, and MRI may all give clues as to the risk for future demyelinating events.

PMID:
19131851
DOI:
10.1097/NRL.0b013e31817acf1a
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center